Enara Bio highlights Dark Antigens™ as a novel class

/PRNewswire/ -- Enara Bio, a biotechnology company advancing novel T cell directed immunotherapies against unconventional, shared, cancer-specific antigens,...

Related Keywords

Boston , Massachusetts , United States , Denmark , Netherlands , United Kingdom , Eleanor Perkin , Racheljm Abbott , Frazer Hall , Enara Bio , Prnewswire Enara Bio , Kevin Pojasek , Head Of Research , Sv Health Investors , Boehringer Ingelheim , Dark Antigen Research , Society For Immunotherapy Of Cancer Annual Meeting , Head Of Research At Enara Bio , Leiden University Medical Center , Francis Crick Institute London , Dark Antigen , Cancer Annual , Cancer Annual Meeting , Dark Antigens , Joseph Dukes , Vice President , Francis Crick Institute , National Centre , Cancer Immune Therapy , Copenhagen Denmark , Samsara Biocapital , Mark Swallow ,